Market Overview

Benzinga's Top Upgrades, Downgrades For May 12, 2020

Share:

Upgrades

  • Guggenheim upgraded the stock for Amneal Pharmaceuticals Inc (NYSE: AMRX) from Sell to Neutral. In the first quarter, Amneal Pharmaceuticals showed an EPS of $0.20, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $11.15 and a 52-week-low of $2.27. Amneal Pharmaceuticals's stock last closed at $4.56 per share.
  • Wedbush upgraded the stock for CarMax Inc (NYSE: KMX) from Neutral to Outperform. CarMax earned $1.30 in the fourth quarter, compared to $1.13 in the year-ago quarter. The stock has a 52-week-high of $103.18 and a 52-week-low of $37.59. CarMax's stock last closed at $76.01 per share.
  • CL King changed the rating for J&J Snack Foods Corp (NASDAQ: JJSF) from Neutral to Buy. J&J Snack Foods earned $0.38 in the second quarter, compared to $1.08 in the year-ago quarter. The stock has a 52-week-high of $196.84 and a 52-week-low of $105.67. J&J Snack Foods's stock last closed at $121.55 per share.
  • For Pinnacle West Capital Corp (NYSE: PNW), Guggenheim upgraded the stock from Neutral to Buy. Pinnacle West Capital earned $0.27 in the first quarter, compared to $0.16 in the year-ago quarter. The stock has a 52-week-high of $105.51 and a 52-week-low of $60.05. Pinnacle West Capital's stock last closed at $73.67 per share.
  • H.C. Wainwright upgraded the stock for Pulse Biosciences Inc (NASDAQ: PLSE) from Neutral to Buy. In the first quarter, Pulse Biosciences showed an EPS of ($0.57), compared to ($0.49) from the year-ago quarter. The stock has a 52-week-high of $17.45 and a 52-week-low of $5.11. Pulse Biosciences's stock last closed at $11.74 per share.
  • Raymond James changed the rating for Uniti Group Inc (NASDAQ: UNIT) from Outperform to Strong Buy. Uniti Group earned $0.45 in the first quarter. The stock has a 52-week-high of $11.85 and a 52-week-low of $4.86. Uniti Group's stock last closed at $7.13 per share.
  • Goldman Sachs upgraded the stock for Axalta Coating Systems Ltd (NYSE: AXTA) from Neutral to Buy. In the first quarter, Axalta Coating Sys showed an EPS of $0.31, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of $32.20 and a 52-week-low of $12.92. Axalta Coating Sys's stock last closed at $19.63 per share.
  • Raymond James changed the rating for CymaBay Therapeutics Inc (NASDAQ: CBAY) from Market Perform to Outperform. For the first quarter, CymaBay Therapeutics had an EPS of ($0.19), compared to year-ago quarter EPS of ($0.37). The stock has a 52-week-high of $13.32 and a 52-week-low of $1.21. CymaBay Therapeutics's stock last closed at $1.84 per share.
  • HSBC upgraded the stock for Liberty Global PLC (NASDAQ: LBTYA) from Hold to Buy. In the first quarter, Liberty Global showed an EPS of $1.50, compared to ($0.43) from the year-ago quarter. The stock has a 52-week-high of $28.62 and a 52-week-low of $15.23. Liberty Global's stock last closed at $21.54 per share.
  • Atlantic Equities changed the rating for Marsh & McLennan Companies Inc (NYSE: MMC) from Neutral to Overweight. Marsh & McLennan earned $1.64 in the first quarter, compared to $1.52 in the year-ago quarter. The stock has a 52-week-high of $119.88 and a 52-week-low of $74.33. Marsh & McLennan's stock last closed at $104.11 per share.
  • Janney Capital upgraded the stock for Eversource Energy (NYSE: ES) from Neutral to Buy. In the first quarter, Eversource Energy showed an EPS of $1.02, compared to $0.97 from the year-ago quarter. The stock has a 52-week-high of $99.42 and a 52-week-low of $60.69. Eversource Energy's stock last closed at $77.01 per share.
  •  

Downgrades

  • Jefferies downgraded the stock for Evelo Biosciences Inc (NASDAQ: EVLO) from Buy to Hold. In the first quarter, Evelo Biosciences showed an EPS of ($0.71), compared to ($0.64) from the year-ago quarter. The stock has a 52-week-high of $10.09 and a 52-week-low of $3.01. Evelo Biosciences's stock last closed at $5.48 per share.
  • For Stanley Black & Decker Inc (NYSE: SWK), B of A Securities downgraded the stock from Buy to Neutral. Stanley Black & Decker earned $1.20 in the first quarter, compared to $1.42 in the year-ago quarter. The stock has a 52-week-high of $173.67 and a 52-week-low of $70.00. Stanley Black & Decker's stock last closed at $113.70 per share.
  • Raymond James downgraded the stock for ON Semiconductor Corp (NASDAQ: ON) from Strong Buy to Outperform. In the first quarter, ON Semiconductor showed an EPS of $0.10, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $25.92 and a 52-week-low of $8.17. ON Semiconductor's stock last closed at $15.66 per share.
  • Goldman Sachs changed the rating for Albemarle Corp (NYSE: ALB) from Buy to Neutral. Albemarle earned $1.00 in the first quarter, compared to $1.23 in the year-ago quarter. The stock has a 52-week-high of $99.40 and a 52-week-low of $48.89. Albemarle's stock last closed at $64.34 per share.
  • Piper Sandler downgraded the stock for Cummins Inc (NYSE: CMI) from Overweight to Neutral. For the first quarter, Cummins had an EPS of $3.18, compared to year-ago quarter EPS of $4.20. The stock has a 52-week-high of $186.72 and a 52-week-low of $101.03. Cummins's stock last closed at $161.89 per share.
  • Goldman Sachs downgraded the stock for CenterPoint Energy Inc (NYSE: CNP) from Buy to Neutral. CenterPoint Energy earned $0.65 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $30.71 and a 52-week-low of $11.58. CenterPoint Energy's stock last closed at $18.18 per share.
  • Imperial Capital changed the rating for Continental Resources Inc (NYSE: CLR) from Outperform to In-Line. Continental Resources earned ($0.08) in the first quarter, compared to $0.58 in the year-ago quarter. The stock has a 52-week-high of $43.77 and a 52-week-low of $6.90. Continental Resources's stock last closed at $14.02 per share.
  • UBS changed the rating for Chevron Corp (NYSE: CVX) from Buy to Neutral. Chevron earned $1.58 in the first quarter, compared to $1.39 in the year-ago quarter. The stock has a 52-week-high of $127.00 and a 52-week-low of $51.60. Chevron's stock last closed at $93.39 per share.
  • For PACCAR Inc (NASDAQ: PCAR), Piper Sandler downgraded the stock from Overweight to Neutral. In the first quarter, PACCAR showed an EPS of $1.03, compared to $1.81 from the year-ago quarter. The stock has a 52-week-high of $83.41 and a 52-week-low of $49.11. PACCAR's stock last closed at $68.83 per share.
  • For Portland General Electric Co (NYSE: POR), Mizuho downgraded the stock from Buy to Neutral. For the first quarter, Portland General Electric had an EPS of $0.91, compared to year-ago quarter EPS of $0.82. The stock has a 52-week-high of $63.08 and a 52-week-low of $37.83. Portland General Electric's stock last closed at $45.03 per share.
  • For Quidel Corp (NASDAQ: QDEL), JP Morgan downgraded the stock from Neutral to Underweight. For the first quarter, Quidel had an EPS of $1.22, compared to year-ago quarter EPS of $0.91. The stock has a 52-week-high of $210.81 and a 52-week-low of $52.49. Quidel's stock last closed at $208.95 per share.
  • Credit Suisse downgraded the stock for Williams Companies Inc (NYSE: WMB) from Outperform to Neutral. Williams Companies earned $0.26 in the first quarter, compared to $0.22 in the year-ago quarter. The stock has a 52-week-high of $29.06 and a 52-week-low of $8.41. Williams Companies's stock last closed at $19.53 per share.
  • Piper Sandler downgraded the stock for Marker Therapeutics Inc (NASDAQ: MRKR) from Overweight to Neutral. In the first quarter, Marker Therapeutics earned ($0.14). The stock has a 52-week-high of $9.17 and a 52-week-low of $1.33. Marker Therapeutics's stock last closed at $2.48 per share.
  •  

Initiations

  • Oppenheimer initiated coverage on Aldeyra Therapeutics Inc (NASDAQ: ALDX) with an Outperform rating. The price target for Aldeyra Therapeutics is set at $12.00. For the first quarter, Aldeyra Therapeutics had an EPS of ($0.34), compared to year-ago quarter EPS of ($0.33). The stock has a 52-week-high of $8.05 and a 52-week-low of $1.48. Aldeyra Therapeutics's stock last closed at $2.96 per share.
  • Oppenheimer initiated coverage on Arvinas Inc (NASDAQ: ARVN) with a Perform rating. For the first quarter, Arvinas had an EPS of ($0.56), compared to year-ago quarter EPS of ($0.46). The stock has a 52-week-high of $58.00 and a 52-week-low of $15.19. Arvinas's stock last closed at $56.74 per share.
  • Cantor Fitzgerald initiated coverage on Premier Inc (NASDAQ: PINC) with an Overweight rating. The price target for Premier is set at $42.00. In the third quarter, Premier showed an EPS of $0.73, compared to $0.66 from the year-ago quarter. The stock has a 52-week-high of $40.13 and a 52-week-low of $27.11. Premier's stock last closed at $30.65 per share.
  • With a rating of Buy, Jefferies initiated coverage on TC Pipelines LP (NYSE: TCP). The price target is set at $39.00 for TC Pipelines. TC Pipelines earned $1.21 in the first quarter, compared to $1.28 in the year-ago quarter. The stock has a 52-week-high of $44.65 and a 52-week-low of $18.00. TC Pipelines's stock last closed at $33.29 per share.
  • Cowen & Co. initiated coverage on Cerence Inc (NASDAQ: CRNC) with an Outperform rating. The price target for Cerence is set at $28.00. Interestingly, in the second quarter, Cerence's EPS was $0.43. The stock has a 52-week-high of $27.28 and a 52-week-low of $11.39. Cerence's stock last closed at $23.85 per share.
 

Related Articles (ALB + ALDX)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
TYGB of A SecuritiesUpgrades
ZIONB of A SecuritiesMaintains39.0
RFB of A SecuritiesMaintains13.0
PNCB of A SecuritiesMaintains123.0
HBANB of A SecuritiesMaintains11.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com